Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. (Q38364806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

A S Abdelmoneim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

D T Eurich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P E Light

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J M Seubert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M J Makowsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S H Simpson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

20 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

523-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

Sulfonylureas: a new look at old therapy

1 March 2020

cites work

1 reference

Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents

21 January 2018

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

Use patterns of antidiabetic regimens by patients with type 2 diabetes

21 January 2018

1 reference

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes

21 January 2018

1 reference

Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians

21 January 2018

1 reference

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.

21 January 2018

1 reference

Do sulfonylurea drugs increase the risk of cardiac events?

21 January 2018

1 reference

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction

21 January 2018

1 reference

Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No.

21 January 2018

1 reference

Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes

21 January 2018

1 reference

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

21 January 2018

1 reference

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry

21 January 2018

1 reference

Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis

21 January 2018

1 reference

Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies

21 January 2018

1 reference

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

21 January 2018

1 reference

Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials

21 January 2018

1 reference

Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

Mortality risk among sulfonylureas: a systematic review and network meta-analysis

21 January 2018

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease

21 January 2018

1 reference

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial

21 January 2018

1 reference

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

Is metformin cardioprotective?

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes

21 January 2018

1 reference

Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial

21 January 2018

1 reference

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

21 January 2018

1 reference

The possibility of unmeasured confounding variables in observational studies: a forgotten fact?

21 January 2018

1 reference

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

21 January 2018

1 reference

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

21 January 2018

1 reference

Instrumental variable methods in comparative safety and effectiveness research

21 January 2018

1 reference

Using secondary data sources for pharmacoepidemiology and outcomes research.

21 January 2018

1 reference

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications

21 January 2018

1 reference

Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study.

21 January 2018

1 reference

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

21 January 2018

1 reference

Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration

21 January 2018

1 reference

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

Electrophysiology of the pancreatic beta-cell

21 January 2018

1 reference

KATP channels and cardiovascular disease: suddenly a syndrome

21 January 2018

1 reference

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

Preconditioning: a paradigm shift in the biology of myocardial ischemia

21 January 2018

1 reference

Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.

21 January 2018

1 reference

Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice

21 January 2018

1 reference

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

21 January 2018

1 reference

ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage

21 January 2018

1 reference

Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.

21 January 2018

1 reference

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

21 January 2018

1 reference

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

21 January 2018

1 reference

Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes.

21 January 2018

1 reference

A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin

21 January 2018

1 reference

Hypoglycemia as a driver of cardiovascular risk in diabetes

21 January 2018

1 reference

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring

21 January 2018

1 reference

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.

21 January 2018

1 reference

Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase

21 January 2018

1 reference

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

21 January 2018

1 reference

The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis

21 January 2018

1 reference

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

21 January 2018

1 reference

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

21 January 2018

1 reference

Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction

21 January 2018

1 reference

Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study

21 January 2018

1 reference

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study

21 January 2018

1 reference

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

21 January 2018

1 reference

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications

21 January 2018

1 reference

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

21 January 2018

1 reference

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study

21 January 2018

1 reference

More reasons to say goodbye to glyburide

21 January 2018

1 reference

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD009008.PUB2

12 January 2024

Identifiers

DOI

10.1111/DOM.12456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25711240%20AND%20SRC:MED&resulttype=core&format=json

release_4olyhlzi4jbthijp6z5b355o6u

1 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4olyhlzi4jbthijp6z5b355o6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference